Nasdaq jumps 1%, Johnson & Johnson keeps Dow down

U.S. equity markets ended mixed after the U.S. Food and Drug Administration recommended Johnson & Johnson’s COVID-19 vaccine be paused amid blood-clotting concerns and consumer prices rose at the fastest pace in over eight years.